BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 28858443)

  • 1. Quality of Life, Functioning, and Depressive Symptom Severity in Older Adults With Major Depressive Disorder Treated With Citalopram in the STAR*D Study.
    Steiner AJ; Recacho J; Vanle B; Dang J; Wright SM; Miller JS; Kauzor K; Reid M; Bashmi LE; Mirocha J; Danovitch I; IsHak WW
    J Clin Psychiatry; 2017 Jul; 78(7):897-903. PubMed ID: 28858443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporating multidimensional patient-reported outcomes of symptom severity, functioning, and quality of life in the Individual Burden of Illness Index for Depression to measure treatment impact and recovery in MDD.
    Cohen RM; Greenberg JM; IsHak WW
    JAMA Psychiatry; 2013 Mar; 70(3):343-50. PubMed ID: 23303512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of Life and Functioning in Comorbid Posttraumatic Stress Disorder and Major Depressive Disorder After Treatment With Citalopram Monotherapy.
    Steiner AJ; Boulos N; Mirocha J; Wright SM; Collison KL; IsHak WW
    Clin Neuropharmacol; 2017; 40(1):16-23. PubMed ID: 27764051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sexual satisfaction and quality of life in major depressive disorder before and after treatment with citalopram in the STAR*D study.
    Ishak WW; Christensen S; Sayer G; Ha K; Li N; Miller J; Nguyen JM; Cohen RM
    J Clin Psychiatry; 2013 Mar; 74(3):256-61. PubMed ID: 23561231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life and functioning of Hispanic patients with Major Depressive Disorder before and after treatment.
    López E; Steiner AJ; Manier K; Shapiro BB; Vanle B; Parisi T; Dang J; Chang T; Ganjian S; Mirocha J; Danovitch I; IsHak WW
    J Affect Disord; 2018 Jan; 225():117-122. PubMed ID: 28826087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major Depressive Disorder in Patients With Doctoral Degrees: Patient-reported Depressive Symptom Severity, Functioning, and Quality of Life Before and After Initial Treatment in the STAR*D Study.
    Steiner AJ; Boulos N; Wright SM; Mirocha J; Smith K; López E; Gohar SH; Ishak WW
    J Psychiatr Pract; 2017 Sep; 23(5):328-341. PubMed ID: 28961662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-reported outcomes of quality of life, functioning, and depressive symptom severity in major depressive disorder comorbid with panic disorder before and after SSRI treatment in the star*d trial.
    IsHak WW; Mirocha J; Christensen S; Wu F; Kwock R; Behjat J; Pi S; Akopyan A; Peselow ED; Cohen RM; Elashoff D
    Depress Anxiety; 2014 Aug; 31(8):707-16. PubMed ID: 23861180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Patient-reported Outcomes of Quality of Life and Functioning Before and After Treatment of Major Depressive Disorder Comorbid With Alcohol Use Disorders.
    Danovitch I; Steiner AJ; Kazdan A; Goldenberg M; Haglund M; Mirocha J; Collison K; Vanle B; Dang J; IsHak WW
    J Addict Med; 2017; 11(1):47-54. PubMed ID: 27763941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting relapse in major depressive disorder using patient-reported outcomes of depressive symptom severity, functioning, and quality of life in the Individual Burden of Illness Index for Depression (IBI-D).
    Ishak WW; Greenberg JM; Cohen RM
    J Affect Disord; 2013 Oct; 151(1):59-65. PubMed ID: 23790554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major Depression Comorbid with Medical Conditions: Analysis of Quality of Life, Functioning, and Depressive Symptom Severity.
    IsHak WW; Steiner AJ; Klimowicz A; Kauzor K; Dang J; Vanle B; Elzahaby C; Reid M; Sumner L; Danovitch I
    Psychopharmacol Bull; 2018 Jan; 48(1):8-25. PubMed ID: 29382957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-reported outcomes before and after treatment of major depressive disorder.
    IsHak WW; Mirocha J; Pi S; Tobia G; Becker B; Peselow ED; Cohen RM
    Dialogues Clin Neurosci; 2014 Jun; 16(2):171-83. PubMed ID: 25152656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A descriptive analysis of quality of life using patient-reported measures in major depressive disorder in a naturalistic outpatient setting.
    Ishak WW; Balayan K; Bresee C; Greenberg JM; Fakhry H; Christensen S; Rapaport MH
    Qual Life Res; 2013 Apr; 22(3):585-96. PubMed ID: 22544416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report.
    Rush AJ; Bernstein IH; Trivedi MH; Carmody TJ; Wisniewski S; Mundt JC; Shores-Wilson K; Biggs MM; Woo A; Nierenberg AA; Fava M
    Biol Psychiatry; 2006 Mar; 59(6):493-501. PubMed ID: 16199008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report.
    Nierenberg AA; Husain MM; Trivedi MH; Fava M; Warden D; Wisniewski SR; Miyahara S; Rush AJ
    Psychol Med; 2010 Jan; 40(1):41-50. PubMed ID: 19460188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STAR*D.
    Gaynes BN; Dusetzina SB; Ellis AR; Hansen RA; Farley JF; Miller WC; Stürmer T
    J Clin Psychopharmacol; 2012 Feb; 32(1):114-9. PubMed ID: 22198447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time Course and Predictors of Suicidal Ideation During Citalopram Treatment in the STAR*D Trial.
    Coughlin CG; Jakubovski E; Bloch MH
    J Clin Psychiatry; 2016 Oct; 77(10):e1262-e1269. PubMed ID: 27631142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trajectories of individual symptoms in remitters versus non-remitters with depression.
    Sakurai H; Uchida H; Abe T; Nakajima S; Suzuki T; Pollock BG; Sato Y; Mimura M
    J Affect Disord; 2013 Nov; 151(2):506-513. PubMed ID: 23886402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of fatigue on outcome of selective serotonin reuptake inhibitor treatment: secondary analysis of STAR*D.
    Ferguson M; Dennehy EB; Marangell LB; Martinez J; Wisniewski SR
    Curr Med Res Opin; 2014 Oct; 30(10):2109-18. PubMed ID: 24949937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machine Learning Prediction of Quality of Life Improvement During Antidepressant Treatment of Patients With Major Depressive Disorder: A STAR*D and CAN-BIND-1 Report.
    Phaterpekar T; Nunez JJ; Morton E; Liu YS; Cao B; Frey BN; Milev RV; Müller DJ; Rotzinger S; Soares CN; Taylor VH; Uher R; Kennedy SH; Lam RW
    J Clin Psychiatry; 2023 Nov; 85(1):. PubMed ID: 37967350
    [No Abstract]   [Full Text] [Related]  

  • 20. Quality of life in major depressive disorder before/after multiple steps of treatment and one-year follow-up.
    IsHak WW; Mirocha J; James D; Tobia G; Vilhauer J; Fakhry H; Pi S; Hanson E; Nashawati R; Peselow ED; Cohen RM
    Acta Psychiatr Scand; 2015 Jan; 131(1):51-60. PubMed ID: 24954156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.